Skip to main content
Hawai'i Journal of Medicine & Public Health logoLink to Hawai'i Journal of Medicine & Public Health
. 2015 Sep;74(9 Suppl 2):43.

Can a Dietary Supplement Induce Autoimmune Hepatitis?

Marina M Roytman 1,2,3,4, Peter Poerzgen 1,2,3,4, Christine LS Lee 1,2,3,4,✉, Leslie Huddleston 1,2,3,4, Peter K Bryant-Greenwood 1,2,3,4, Timothy Kuo 1,2,3,4, Linda L Wong 1,2,3,4, Naoky Tsai 1,2,3,4
PMCID: PMC4582385

Abstract

Purpose

The etiology of autoimmune hepatitis (AIH) is largely unknown, but xenobiotics, rare viruses and drugs like minocycline and nitrofurantoin have been implicated. With this report we want to bring attention to dietary supplements as a possible trigger for AIH. OxyElite Pro New Formulation (USPlabs, Dallas, Texas), a popular weight-loss herbal dietary supplement was linked to severe hepatotoxicity in 56 patients across the United States. Our center has encountered 35 of these cases and seen most of them recover after discontinuation of OxyElite Pro. We now report a subgroup of patients that went on to developed AIH.

Methods

Clinical data on demographics, drug use, laboratory studies, biopsies and outcomes were collected. We assessed causality and severity of liver injury according to Roussel Uclaf Causality Assessment Method/ Council for International Organizations of Medical Sciences (RUCAM/CIOMS) scale and Drug-Induced Liver Injury Network (DILIN) method respectively. We assessed likelihood of AIH diagnosis using the Revised Original Scoring System of the International Autoimmune Hepatitis Group.

Results

35 patients with acute liver injury were identified at our medical center between May 2013 and January 2014. Two patients were transplanted, two died, 25 recovered. Six patients continued to have progressive worsening of liver function despite discontinuation of OxyElite Pro. Four out of six patients were hospitalized at initial presentation, all had liver biopsies. Histology was consistent with AIH and distinctly different from other patients with OxyElite Pro DILI. All six patients were treated with corticosteroids and entered remission thus strengthening the diagnosis of AIH. Use of the Revised Original Scoring System revealed 2 cases as definite and 3 cases as probable.

Conclusions

We report six cases of AIH in the setting of DILI due to OxyElite Pro in a five month period (August 2013–January 2014) observed in a single center. We postulate that DILI due to OxyElite Pro has induced de novo AIH or unmasked preexisting, quiescent disease.

Footnotes

(This poster has previously been presented at the American Association for the Study of Liver Diseases 2014 conference in Boston, MA.)

Conflict of Interest

The authors report no conflict of interest.


Articles from Hawai'i Journal of Medicine & Public Health are provided here courtesy of University Health Partners of Hawaii

RESOURCES